Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3

Author: Mahy P.   De Bast M.   Leveque P.   Gillart J.   Labar D.   Marchand J.   Gregoire V.  

Publisher: Springer Publishing Company

ISSN: 1619-7070

Source: European Journal of Nuclear Medicine and Molecular Imaging, Vol.31, Iss.9, 2004-09, pp. : 1263-1272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content